Not Signed In - Astellas Terminates Agreement On Acute Heart Failure Agent Carperitide
Sun, 28 Jan 2007 08:00 AM EST
... Astellas Pharma Inc. today announced that its US affiliate, Astellas US LLC, has terminated its license agreement with Daiichi Asubio Pharma Co., Ltd. (Tokyo) regarding North American and European Union rights to carperitide for the treatment of acute heart failure.Astellas US LLC's predecessor, Fujisawa Healthcare, Inc. and Daiichi Asubio Pharma's predecessor, Daiichi Suntory Pharma Co., Ltd. [click link for full article] ...
Related Topics
- Congestive Heart Failure
- Kidney Failure
- Agent Orange
- Chemical Agents
- Heart Attack
- Heart Disease
- Coronary Heart Disease
- Heart Defects
- Heart Murmur
- Heart Diseases
- Acute Care
- Acute kidney failure
- BNP
- Right-sided heart failure
- Heart and Circulation
- Heart failure or abnormal rhythm
- Left-sided heart failure
- Congestive heart failure (rare)
- Congenital Heart Disease
- Heart Bypass Surgery
email this page
print this page
bookmark this page
feedback on this page
